Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease

Condition:   Nonobstructive Coronary Artery Disease
Intervention:   Other: Slow-paced walking
Sponsor:   University of Florida
Recruiting - verified June 2015

Vascular Responses to UV Exposure in Pregnancy

Condition:   Pregnancy
Interventions:   Radiation: UVA radiation;   Radiation: Sham Control
Sponsors:   University of Edinburgh;   NHS Lothian
Not yet recruiting - verified June 2015

Iloprost for Bridging to Heart Transplantation in PH

Conditions:   Chronic Left Ventricular Failure;   Pulmonary Hypertension
Interventions:   Drug: Inhaled Iloprost;   Drug: Placebo
Sponsors:   Heidelberg University;   Bayer
Withdrawn - verified June 2015

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   The Cleveland Clinic
Recruiting - verified June 2015

IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers

Condition:   Influence of 8 Months of Increased Physical Activity Workload on Osteoprotegerin and Endocan Levels
Intervention:   Other: Increased sports workload
Sponsors:   Medical University of Vienna;   Austrian Federal Ministry of Defence and Sports
Recruiting - verified June 2015

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified June 2015

Beraprost-314d Added-on to Tyvaso® (BEAT)

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
Sponsor:   Lung Biotechnology PBC
Recruiting - verified June 2015

Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Conditions:   Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:  
Sponsor:   University of Aarhus
Recruiting - verified June 2015

X-chromosome Inactivation, Epigenetics and the Transcriptome

Conditions:   Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:  
Sponsors:   University of Aarhus;   Lundbeck Foundation;   The Korning Foundation Denmark;   AP Moeller Foundation
Active, not recruiting - verified June 2015

Effects of Amino Acids on Regional Lipid Metabolism

Condition:   Hypertriglyceridemia
Interventions:   Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
Sponsors:   University of Arkansas;   National Institute on Aging (NIA)
Recruiting - verified June 2015

Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

Condition:   Coronary Artery Disease
Interventions:   Drug: Exercise plus Regadenoson (Lexercise);   Drug: Regadenoson (Lexiscan)
Sponsor:   Brigham and Women's Hospital
Recruiting - verified June 2015

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions:   Device: Bone marrow concentration device;   Procedure: Placebo procedure (sham)
Sponsor:   Biomet Biologics, LLC
Active, not recruiting - verified June 2015

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Conditions:   Brain Ischemia;   Intracranial Hemorrhages
Interventions:   Drug: Cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: placebo of aspirin;   Device: ankle-brachial index (ABI);   Device: intima-medial thickness (IMT);   Device: new asymptomatic brain hemorrhage;   Device: new ischemic lesions on follow-up FLAIR images
Sponsors:   Asan Medical Center;   Korea Otsuka Pharmaceutical Co.,Ltd.
Active, not recruiting - verified June 2015

Get CardioSmart

You're Invited